Home/Senhwa Biosciences/Hsin-Hua Chang
HC

Hsin-Hua Chang

Chief Financial Officer

Senhwa Biosciences

Therapeutic Areas

Senhwa Biosciences Pipeline

DrugIndicationPhase
Silmitasertib (CX-4945)CholangiocarcinomaPhase II
Pidnarulex (CX-5461)Solid Tumors with HRDPhase I